Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
---|---|
Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
ClinicalTrials.gov Identifier: | NCT00104546 |
The purpose of this study is to test the feasibility and effectiveness of vitamin K injections into certain body parts for the treatment of painful menstruation.
Condition | Intervention | Phase |
---|---|---|
Dysmenorrhea |
Procedure: Acupuncture point injection of vitamin K |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Vitamin K Injection Treatment for Primary Dysmenorrhea: A Controlled Pilot Study |
Estimated Enrollment: | 36 |
Study Start Date: | September 2004 |
Study Completion Date: | March 2006 |
Primary Completion Date: | March 2006 (Final data collection date for primary outcome measure) |
Painful menstruation, also known as dysmenorrhea, is a common problem affecting a significant percentage of women. In the United States and Europe, nonsteroidal anti-inflammatory drugs (NSAIDs) and oral contraceptives are the most commonly prescribed treatments for this condition. However, in China, oral contraceptives are not commonly prescribed for unmarried women. Acu-injection, a procedure involving the injection of vitamin K into acupuncture points, has become standard treatment for dysmenorrhea at many Chinese health care facilities. This trial will assess the willingness of young Chinese women to participate in an acu-injection trial, explore the utility of pain measurements after injection, and determine the effectiveness of the injections. This study will also help in planning larger acu-injection clinical trials.
This study will last for five menstrual cycles. Participants will be randomly assigned to one of three groups. Group 1 participants will receive a vitamin K3 injection in an acupuncture point of both legs and a saline injection in the right buttock. Group 2 participants will receive a saline injection in an acupuncture point of both legs and a saline injection in the right buttock. Group 3 participants will receive a saline injection in a pseudo-acupuncture point of both legs and a vitamin K3 injection in the right buttock. Injections will be administered one time during the first 2 days of the first menstrual cycle for participants who are experiencing menstrual pain. Participants will record their level of menstrual pain before injection and at 2, 5, 30 and 60 minutes after the injections. Participants who do not respond to or are not satisfied with the acu-injection treatment will be offered either Chinese herbal medicine or NSAIDs within 1 hour of the injection. After the injection visit, participants will be asked to complete questionnaires about any menstrual pain or side effects they may be experiencing for five subsequent menstrual cycles.
Ages Eligible for Study: | 14 Years to 25 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
China | |
Menstrual Disorder Clinic of the OBS/GYN Hospital of Fudan University | |
Shanghai, China |
Principal Investigator: | Fredi Kronenberg, PhD | Columbia University College of Physicians and Surgeons |
Study ID Numbers: | R21 AT001957 |
Study First Received: | March 1, 2005 |
Last Updated: | January 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00104546 History of Changes |
Health Authority: | United States: Federal Government |
Dysmenorrhea Acupuncture Vitamin K Medicine, Chinese Traditional |
Women Menstruation Pain, Menstrual China |
Pain Trace Elements Hemostatics Signs and Symptoms Antiplasmin Fibrin Modulating Agents Pelvic Pain |
Antifibrinolytic Agents Dysmenorrhea Menstruation Disturbances Vitamins Vitamin K Micronutrients |
Coagulants Molecular Mechanisms of Pharmacological Action Growth Substances Physiological Effects of Drugs Hematologic Agents Pain Pharmacologic Actions Hemostatics Signs and Symptoms Fibrin Modulating Agents |
Pathologic Processes Pelvic Pain Antifibrinolytic Agents Dysmenorrhea Menstruation Disturbances Therapeutic Uses Vitamins Vitamin K Micronutrients |